|
|
 |
|
Viewing report
|
|
|
|
Autoimmune Disease Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2011, Pages: 749
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns Disease (Biologics), and Others. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.The report profiles 112 companies including many key and niche players such as Abbott Laboratories, Amgen Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Elan Corporation, plc, Eli Lilly And Company, F. Hoffmann-La Roche AG, Chugai Pharmaceutical Co., Ltd., Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck & Co., Inc, Merck Serono SA, Novartis AG, Sanofi-aventis SA , Shire Plc, Teva Pharmaceuticals Industries Limited, and UCB S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Radiopharmaceuticals - Global Strategic Business Report
Botulinum Toxin - Global Strategic Business Report
Spinal Surgery - Global Strategic Business Report
Nanobiotechnology - Global Strategic Business Report
Nanotechnology - Global Strategic Business Report
Nanobiotechnology Applications, Markets and Companies
Chiral Technology - Global Strategic Business Report
Computer Aided Detection (CAD) - Global Strategic Business Report
Tunable Lasers - Global Strategic Business Report
Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report
|
|
|
|
